4/A//SEC Filing
McGrath Lynne Fahey 4/A
Accession 0001214659-22-004992
CIK 0001677077other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 5:00 PM ET
Size
5.3 KB
Accession
0001214659-22-004992
Insider Transaction Report
Form 4/AAmended
McGrath Lynne Fahey
Director
Transactions
- Sale
Common Stock
2022-03-28$1.21/sh−25,000$30,325→ 75,000 total
Footnotes (2)
- [F1]The original Form 4 filed on April 6, 2022, is amended by this Form 4 amendment to correct a typographical error in Table I Column 4 from "A" to "D".
- [F2]The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average purchase price of $1.213. The range of sale prices on the transaction date was $1.19 to $1.23 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
Documents
Issuer
Alzamend Neuro, Inc.
CIK 0001677077
Entity typeother
Related Parties
1- filerCIK 0001866270
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 5:00 PM ET
- Size
- 5.3 KB